4-HYDROXY-2,2-DIMETHYL-2,3-DIHYDRO-BENZOFURAN-6-CARBOXYLIC ACID METHYL ESTER, 95%, 2g

3-Amino-5,7-dimethyl-2h,4h,5h,6h,7h-pyrazolo[3,4-d]pyrimidine-4,6-dione, 95%, 100mg

tert-Butyl 7-(hydroxymethyl)-2-azaspiro[4.4]nonane-2-carboxylate, 97%, 500mg

2-MORPHOLINOETHYL (E)-6-(4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-1,3-DIHYDROISOBENZOFURAN-5-YL)-4-METHYLHEX-4-ENOATE, 95%, 250mg

(R)-1-(5-Bromo-2-fluorophenyl)ethan-1-ol, 98%, 500mg

2-Bromo-1-[4-(difluoromethoxy)-3-methoxyphenyl]ethan-1-one, 95%, 1g

Objectif IOS plan longue distance de travail 4x/0,13, corrigé pour 1 mm d'épaisseur

2-[(4-Methoxy-phenylamino)-methyl]-phenol, 250mg

5-BOC-3-METHYL-4,6-DIHYDRO-1H-PYRROLO[3,4-C]PYRAZOLE, 95.0%, 5g

1,2,3,4-Tetrahydro-1,6-naphthyridine, 95.0%, 5g

3-Thiopheneethanol, 98.0%, 1g

5-Methyl-1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 97%, 5g

2-(2-Aminoethoxy)ethanol>98.0%(GC)(T)500mL